Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Revolution Medicines, Inc.(RVMD) | 7,601,087 | 7,601,087 | 0 | $1.42B | $1.56B | 69.89% | +$136.67M |
| Parabilis Medicines Inc | 4,663,176 | 4,663,176 | 0 | $127.63M | $150.57M | 6.75% | +$22.94M |
| Relay Therapeutics, Inc.(RLAY) | 6,776,506 | 6,776,506 | 0 | $126.79M | $122.32M | 5.48% | -$4.47M |
| Oric Pharmaceuticals Inc | 7,162,637 | 7,162,637 | 0 | $77.57M | $96.48M | 4.32% | +$18.91M |
| Tyra Biosciences, Inc.(TYRA) | 3,553,585 | 3,447,482 | -106,103 | $113.50M | $75.40M | 3.38% | -$38.11M |
| Alumis Inc | 3,540,998 | 4,550,998 | +1,010,000 | $99.64M | $33.63M | 1.51% | -$66.01M |
| Attovia Therapeutics Inc | 0 | 1,835,139 | +1,835,139 | $0 | $31.45M | 1.41% | +$31.45M |
| Kymera Therapeutics, Inc.(KYMR) | 278,896 | 278,896 | 0 | $31.98M | $31.18M | 1.40% | -$803.2K |
| Electra Therapeutics Inc | 0 | 2,636,225 | +2,636,225 | $0 | $29.66M | 1.33% | +$29.66M |
| Zymeworks Inc.(ZYME) | 1,113,946 | 1,113,946 | 0 | $29.12M | $29.51M | 1.32% | +$389.9K |
| Silence Therapeutics plcADS(SLN) | 952,400 | 1,693,140 | +740,740 | $10.46M | $18.51M | 0.83% | +$8.05M |
| Cytomx Therapeutics Inc. | 4,449,932 | 4,449,932 | 0 | $16.69M | $12.10M | 0.54% | -$4.58M |
| Avalo Therapeutics Inc | 0 | 766,000 | +766,000 | $0 | $11.74M | 0.53% | +$11.74M |
| Monte Rosa Therapeutics Inc | 761,153 | 761,153 | 0 | $18.42M | $9.08M | 0.41% | -$9.34M |
| Braveheart Bio Inc | 0 | 416,700 | +416,700 | $0 | $8.42M | 0.38% | +$8.42M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 450,000 | 450,000 | 0 | $6.72M | $5.18M | 0.23% | -$1.54M |
| Engene Therapeutics Inc | 2,324,943 | 2,324,943 | 0 | $4.02M | $4.65M | 0.21% | +$627.7K |
| Context Therapeutics Inc | 7,419,355 | 7,419,355 | 0 | $4.11M | $2.23M | 0.10% | -$1.88M |
| Arvinas, Inc.(ARVN) | 1,122,713 | 0 | -1,122,713 | $17.12M | $0 | — | -$17.12M |